针对原发性肝癌的传统治疗方法疗效欠佳、预后较差,基因治疗成为新的研究方向和热点。新的基因治疗策略不断涌现,载体系统不断更新,导人方法不断优化,动物模型不断改进,本研究就以上方面进行综述。 Traditional treatment for primary liver cancer has poor efficacy and poor prognosis. Gene therapy has become a new research direction and hotspot. New gene therapy strategies are constantly emerging, carrier systems are continuously updated, human methods are continuously optimized, and animal models are continuously improved. This study reviews the above aspects.